Beam Therapeutics BEAM Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech GSBC Q1 2026 Earnings Strong EPS Beat Despite Slight Stock Decline Capital Southwest Corporation Q1 2026 Earnings EPS Misses Estimates Stock Slips PSO Q4 2025 Earnings Modest EPS Beat Highlights Steady Execution RKT Q1 2026 Earnings EPS Surpasses Estimates by 256 Amid Challenging Market